Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease
Open Access
- 22 September 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (18)
Abstract
Dysfunctional dopaminergic neurotransmission is central to movement disorders and mental diseases. The dopamine transporter (DAT) regulates extracellular dopamine levels, but the genetic and mechanistic link between DAT function and dopamine-related pathologies is not clear. Particularly, the pathophysiological significance of monoallelic missense mutations in DAT is unknown. Here, we use clinical information, neuroimaging, and large-scale exome-sequencing data to uncover the occurrence and phenotypic spectrum of a DAT coding variant, DAT-K619N, which localizes to the critical C-terminal PSD-95/Discs-large/ZO-1 homology–binding motif of human DAT (hDAT). We identified the rare but recurrent hDAT-K619N variant in exome-sequenced samples of patients with neuropsychiatric diseases and a patient with early-onset neurodegenerative parkinsonism and comorbid neuropsychiatric disease. In cell cultures, hDAT-K619N displayed reduced uptake capacity, decreased surface expression, and accelerated turnover. Unilateral expression in mouse nigrostriatal neurons revealed differential effects of hDAT-K619N and hDAT-WT on dopamine-directed behaviors, and hDAT-K619N expression in Drosophila led to impairments in dopamine transmission with accompanying hyperlocomotion and age-dependent disturbances of the negative geotactic response. Moreover, cellular studies and viral expression of hDAT-K619N in mice demonstrated a dominant-negative effect of the hDAT-K619N mutant. Summarized, our results suggest that hDAT-K619N can effectuate dopamine dysfunction of pathological relevance in a dominant-negative manner.Keywords
All Related Versions
Funding Information
- Independent Research Fund Denmark – Medical Sciences (DFF-4183-00571)
- Independent Research Fund Denmark – Medical Sciences (DFF 4004-00097B)
- Lundbeck Foundation (R181-2014-3090)
- Lundbeck Foundation (R303-2018-3540)
- Lundbeck Foundation (R223-2016-261)
- Augustinus Fonden (11870)
- Foundation for the National Institutes of Health (DA035263)
- Foundation for the National Institutes of Health (Z1A DA000610)
This publication has 65 references indexed in Scilit:
- Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic MiceScience, 2012
- A Modular Toolset for Recombination Transgenesis and Neurogenetic Analysis of DrosophilaPLOS ONE, 2012
- Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findingsJournal of Neurodevelopmental Disorders, 2012
- Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking RegulationJournal of Neuroscience, 2012
- How Addictive Drugs Disrupt Presynaptic Dopamine NeurotransmissionNeuron, 2011
- Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental studyThe Lancet Neurology, 2011
- Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystoniaJournal of Clinical Investigation, 2009
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common PathwaySchizophrenia Bulletin, 2009
- Monomeric fluorescent timers that change color from blue to red report on cellular traffickingNature Chemical Biology, 2009
- Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporterProceedings of the National Academy of Sciences, 2008